Intuitive Surgical (ISRG) & Its Peers Financial Comparison

Intuitive Surgical (NASDAQ: ISRG) is one of 83 publicly-traded companies in the “Advanced Medical Equipment & Technology” industry, but how does it contrast to its competitors? We will compare Intuitive Surgical to similar businesses based on the strength of its earnings, valuation, dividends, risk, institutional ownership, profitability and analyst recommendations.

Earnings & Valuation

This table compares Intuitive Surgical and its competitors revenue, earnings per share and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Intuitive Surgical $2,704.40 $735.90 49.06
Intuitive Surgical Competitors $2,169.89 $226.13 -13.74

Intuitive Surgical has higher revenue and earnings than its competitors. Intuitive Surgical is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent ratings for Intuitive Surgical and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intuitive Surgical 0 5 11 0 2.69
Intuitive Surgical Competitors 267 1850 3312 105 2.59

Intuitive Surgical currently has a consensus price target of $139.91, indicating a potential downside of 63.16%. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 6.07%. Given Intuitive Surgical’s competitors higher probable upside, analysts clearly believe Intuitive Surgical has less favorable growth aspects than its competitors.

Insider and Institutional Ownership

31.4% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 51.1% of shares of all “Advanced Medical Equipment & Technology” companies are owned by institutional investors. 2.2% of Intuitive Surgical shares are owned by insiders. Comparatively, 18.7% of shares of all “Advanced Medical Equipment & Technology” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.


This table compares Intuitive Surgical and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Intuitive Surgical 30.16% 18.20% 15.90%
Intuitive Surgical Competitors -347.75% -35.97% -13.30%

Risk and Volatility

Intuitive Surgical has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Comparatively, Intuitive Surgical’s competitors have a beta of 0.90, meaning that their average share price is 10% less volatile than the S&P 500.


Intuitive Surgical beats its competitors on 8 of the 13 factors compared.

About Intuitive Surgical

Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company’s instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.

What are top analysts saying about Intuitive Surgical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Intuitive Surgical Inc. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit